Search Videos and More
Illuminating cancer: New pH threshold sensor improves cancer surgery
The high acidity of cancer cells yielded the clue that led to the development of a tool that significantly improves surgeons’ abilities to remove cancerous tissues. The invention by UT Southwestern researchers is a transistor-like threshold sensor that hones in on high pH, literally lighting up cancerous cells.UT Southwestern researchers seek to light up cancer cells so surgeons can better see where to cut
Baran Sumer, M.D. Professor and Chief of the Division of Head and Neck Oncology in UT Southwestern’s Department of Otolaryngology and a team of researchers from the Simmons Comprehensive Cancer Center developed a technology called a pH Nanosensor, an injection that seeks out cancerous areas in the body and causes them to light up.A transistor-like pH nanoprobe for tumour detection and image-guided surgery
UT Southwestern’s Baran Sumer, M.D., Professor and Chief of the Division of Head and Neck Oncology in the Department of Otolaryngology is among other researchers to report the design and performance of a fluorescent nanoprobe with transistor-like responses (transition pH?=?6.9) for the detection of deregulated pH, which drives many of the invasive properties of cancer.Gut microbiome offers clues to disparities in rectal cancer
UT Southwestern study identifies clustering of specific gut bacteria associated with race, ethnicity in patientsFactors Associated with Lymph Node Count in Head and Neck Cancer
Surgeons from the University of Texas Southwestern Medical Center carried-out a restrospective study on 247 patients with head and neck cancer to test whether age and undernutrition, factors known to negatively affect immune function, decreased lymph-node count in patients undergoing neck dissection.Cancer Researchers are “Lighting Up” Cancer
Learn how cancer researchers are “lighting up” cancer by watching our Facebook Live chat with otolaryngologist Baran Sumer, M.D. Dr. Sumer is part of a team that developed a transistor-like nanosensor that can illuminate cancerous cells to assist surgeons.Nanoparticles developed at UTSW effectively fight tumors
Activating a specific pathway in a subset of immune cells eradicates immunologically ‘cold’ tumors, UTSW study showsHow Glen’s journey to getting a power wheelchair got much smoother
Glen Denehie is a substitute teacher, soccer fanatic, home cook, and dad of two busy teens. He also has facioscapulohumeral muscular dystrophy (FSHD), one of 30 forms of muscular dystrophy.Ethnic minorities face higher risk of liver transplant failure
UTSW study of patients with alcohol-associated diseases could lead to interventions that improve outcomes of these proceduresLung cancer treatment shows promise in tumor models
UT Southwestern study uses 6-thio-dG molecule to damage DNA and halt spread of small cell lung cancerWhy Cancer Care Specialization Matters: The Story of a CLL Survivor
After undergoing a routine physical in September 2015, William Marks was diagnosed with chronic lymphocytic leukemia (CLL). Following an initial consultation with an oncologist, Mr. Marks left feeling more bewildered and distressed than when he first received his diagnosis.UTSW Simmons Cancer Center Welcomes New Deputy Director for Clinical Affairs
UT Southwestern welcomes Jason B. Fleming, M.D., FACS, as Deputy Director for Clinical Affairs of the Harold C. Simmons Comprehensive Cancer Center. An internationally recognized surgical oncologist specializing in the treatment of pancreatic cancer, Dr. Fleming rejoins UT Southwestern from the Moffitt Cancer Center in Tampa, Fla., where he was Chair of Gastrointestinal Oncology.